Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
house dust mite allergen extract (HAL Allergy Group)
- Development stage
- Phase 2
- Lead developer
- HAL Allergy
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Sublingual
01
Overview
Sublivac Fix Mite mixture is a sublingual immunotherapy (SLIT) developed by HAL Allergy for the treatment of allergic rhinitis and rhinoconjunctivitis caused by a sensitization to house dust mite (HDM) allergens. It is a liquid preparation of standardized house dust mite allergen extracts administered as drops under the tongue. The therapy works by gradually exposing the immune system to increasing amounts of the allergen, which can desensitize the patient and alter the natural course of the allergic disease, potentially reducing symptoms and the need for other medications over the long term. Clinical trials have been conducted to determine the optimal dosage, safety, and tolerability of different concentrations of the mixture.
- Brand names
- Sublivac Fix Mite mixtureSUBLIVAC
- Other names
- SLIT Mites
02
Targets
IgE (Immunoglobulin E)
Beyond the preview
Go deeper on house dust mite allergen extract (HAL Allergy Group).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on house dust mite allergen extract (HAL Allergy Group).